Spectral Diagnostics Shares Outstanding 2012-2025 | EDTXF
Spectral Diagnostics shares outstanding from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Spectral Diagnostics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 281 |
| 2023 | 279 |
| 2022 | 270 |
| 2021 | 252 |
| 2020 | 233 |
| 2019 | 226 |
| 2018 | 220 |
| 2017 | 207 |
| 2016 | 205 |
| 2015 | 188 |
| 2014 | 155 |
| 2013 | 126 |
| 2012 | 114 |
| 2011 | 91 |
|
Spectral Diagnostics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 287 |
| 2025-06-30 | 285 |
| 2025-03-31 | 285 |
| 2024-12-31 | 281 |
| 2024-09-30 | 282 |
| 2024-06-30 | 280 |
| 2024-03-31 | 279 |
| 2023-12-31 | 279 |
| 2023-09-30 | 279 |
| 2023-06-30 | 279 |
| 2023-03-31 | 279 |
| 2022-12-31 | 270 |
| 2022-09-30 | 268 |
| 2022-06-30 | 268 |
| 2022-03-31 | 268 |
| 2021-12-31 | 252 |
| 2021-09-30 | 261 |
| 2021-06-30 | 244 |
| 2021-03-31 | 237 |
| 2020-12-31 | 233 |
| 2020-09-30 | 237 |
| 2020-06-30 | 229 |
| 2020-03-31 | 227 |
| 2019-12-31 | 226 |
| 2019-09-30 | 226 |
| 2019-06-30 | 226 |
| 2019-03-31 | 226 |
| 2018-12-31 | 220 |
| 2018-09-30 | 226 |
| 2018-06-30 | 222 |
| 2018-03-31 | 208 |
| 2017-12-31 | 207 |
| 2017-09-30 | 207 |
| 2017-06-30 | 207 |
| 2017-03-31 | 207 |
| 2016-12-31 | 205 |
| 2016-09-30 | 207 |
| 2016-06-30 | 207 |
| 2016-03-31 | 198 |
| 2015-12-31 | 188 |
| 2015-09-30 | 191 |
| 2015-06-30 | 191 |
| 2015-03-31 | 180 |
| 2014-12-31 | |
| 2014-09-30 | 169 |
| 2014-06-30 | 123 |
| 2014-03-31 | 134 |
| 2013-12-31 | 122 |
| 2013-09-30 | 133 |
| 2013-06-30 | 132 |
| 2013-03-31 | 114 |
| 2012-12-31 | 114 |
| 2012-09-30 | 114 |
| 2012-06-30 | 114 |
| 2012-03-31 | 114 |
| 2011-12-31 | 195 |
| 2011-09-30 | 88 |
| 2011-06-30 | 81 |
| 2011-03-31 | 81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.281B | $0.002B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $239.063B | 28.41 |
| Intuitive Surgical (ISRG) | United States | $187.731B | 73.45 |
| IDEXX Laboratories (IDXX) | United States | $55.613B | 55.23 |
| Edwards Lifesciences (EW) | United States | $49.407B | 33.13 |
| IQVIA Holdings (IQV) | United States | $41.110B | 22.92 |
| Alcon (ALC) | Switzerland | $40.371B | 27.21 |
| Mettler-Toledo (MTD) | United States | $29.477B | 34.49 |
| DexCom (DXCM) | United States | $28.124B | 38.77 |
| STERIS (STE) | Ireland | $25.634B | 26.46 |
| Waters (WAT) | United States | $23.623B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.267B | 32.88 |
| Hologic (HOLX) | United States | $16.749B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.665B | 0.00 |
| Penumbra (PEN) | United States | $14.008B | 98.53 |
| Globus Medical (GMED) | United States | $12.601B | 26.45 |
| Masimo (MASI) | United States | $7.854B | 25.17 |
| Glaukos (GKOS) | United States | $7.131B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.163B | 19.58 |
| TransMedics (TMDX) | United States | $4.573B | 54.17 |
| Teleflex (TFX) | United States | $4.550B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.455B | 18.66 |
| Veracyte (VCYT) | United States | $3.423B | 39.01 |
| Integer Holdings (ITGR) | United States | $3.048B | 14.31 |
| Alphatec Holdings (ATEC) | United States | $2.530B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.422B | 22.66 |
| Artivion (AORT) | United States | $2.099B | 96.33 |
| UFP Technologies (UFPT) | United States | $2.045B | 27.00 |
| Nihon Kohden (NHNKY) | Japan | $1.953B | 17.05 |
| PROCEPT BioRobotics (PRCT) | United States | $1.729B | 0.00 |
| AxoGen (AXGN) | United States | $1.523B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.406B | 0.00 |
| IRadimed (IRMD) | United States | $1.313B | 62.56 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.973B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| SiBone (SIBN) | United States | $0.737B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.731B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.725B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.681B | 39.62 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.597B | 11.91 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.550B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.467B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.436B | 0.00 |
| RxSight (RXST) | United States | $0.409B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| Sight Sciences (SGHT) | United States | $0.337B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Anteris Technologies Global (AVR) | Australia | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.204B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.125B | 0.00 |
| Hyperfine (HYPR) | United States | $0.124B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.42 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |